Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02288364 · ClinicalTrials.gov registry record · Phase 4
Reducing Pain of Lidocaine Injection
A Phase 4 study of Pain of Anesthesia at Breast Biopsy, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 88
- Enrollment target
- 1
- Study location
NCT02288364 is a Phase 4 study of Pain of Anesthesia at Breast Biopsy that has completed, run by Duke University. The registered enrollment target is 88 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02288364, a Phase 4 study of Pain of Anesthesia at Breast Biopsy, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the benefit, if any, of buffering lidocaine (adding sodium bicarbonate) when used for local anesthesia prior to percutaneous breast needle core biopsies. The medicine doctors use to reduce the pain of breast biopsies, lidocaine, can cause pain for approximately 15 seconds until the numbing effect begins. It is possible that this pain is caused because lidocaine is acidic. Some physicians believe that reducing the acidity of lidocaine by mixing it with sodium bicarbonate will reduce the initial pain of injecting the lidocaine. Both approaches - injecting 1% lidocaine alone and injecting 1% lidocaine mixed with sodium bicarbonate - are used as routine standard of care by radiologists today. The purpose of this study is to determine if either approach is more comfortable for patients having breast procedures.
Conditions Studied
Interventions
- DRUG 1% Lidocaine
- DRUG 1% Lidocaine plus sodium bicarbonate
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2014-12 |
| Est. Completion | 2015-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02288364
The ClinicalTrials.gov registry entry for NCT02288364 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pain of Anesthesia at Breast Biopsy appearing as the primary indexed condition, and to 2 interventions - of which 1% Lidocaine is the first listed.
NCT02288364 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT02288364 about?
NCT02288364 is a clinical study titled "Reducing Pain of Lidocaine Injection". The purpose of this study is to determine the benefit, if any, of buffering lidocaine (adding sodium bicarbonate) when used for local anesthesia prior to percutaneous breast needle core biopsies. The medicine doctors use to reduce the pain of breast biopsies, lidocaine, can cause pain for approximat...
What is the current status of trial NCT02288364?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 88 participants. The study started on 2014-12. Estimated completion is 2015-08.
What conditions does trial NCT02288364 study?
This clinical trial studies the following conditions: Pain of Anesthesia at Breast Biopsy.
What interventions are being tested in trial NCT02288364?
The interventions under investigation include: 1% Lidocaine (DRUG), 1% Lidocaine plus sodium bicarbonate (DRUG).
Who is sponsoring clinical trial NCT02288364?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02288364 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.